Biotech | July 16, 2022
Enveric Biosciences advances drug development for mental health indications
Advancing to IND-enabling studies with multiple drug candidates
Advancing to IND-enabling studies with multiple drug candidates
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumour microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Subscribe To Our Newsletter & Stay Updated
